Papers
4
Total Citations
49
H-Index
3
About
Michael S. Leapman is a urologic oncologist and surgeon-scientist whose research focuses on improving surgical outcomes and expanding access to care for men with prostate cancer. He is particularly known for his work in optimizing recovery after radical prostatectomy, including a landmark randomized trial that investigated the use of an autologous retropubic urethral sling—fashioned from the patient’s own vas deferens—to hasten the return of urinary continence following robotic-assisted surgery. This work, published in 2016, has garnered 23 citations and highlights his commitment to innovative, patient-centered surgical techniques. Leapman has also contributed to understanding prostate cancer in underserved populations, including a study characterizing the clinical features and outcomes of HIV-seropositive men undergoing surgery for prostate cancer. More recently, he has been at the forefront of evaluating single-port robot-assisted radical prostatectomy, comparing its perioperative outcomes to conventional multiport approaches. With a career marked by both technical innovation and a focus on health equity, Leapman’s research continues to shape the landscape of prostate cancer surgery and recovery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4